Prostate Cancer Focal Therapy Using MRI and Ultrasound Fusion-Guided Brachytherapy
Prostate cancer treatment is evolving toward precision medicine, with MRI and ultrasound fusion-guided brachytherapy representing a groundbreaking advancement. The brachytherapy market is benefiting from this trend, as clinicians use advanced imaging to identify and treat only cancerous regions of the prostate while sparing healthy tissue. This focal therapy approach minimizes side effects such as urinary incontinence and erectile dysfunction, significantly improving patients’ quality of life.
The process involves overlaying high-resolution MRI images with real-time ultrasound scans to create a detailed map of the prostate. Radioactive seeds or HDR catheters are then precisely placed in the tumor zone. By delivering targeted radiation, the technique reduces unnecessary exposure to surrounding organs, enabling effective treatment with fewer complications. This method is particularly valuable for patients with localized, low-to-intermediate risk prostate cancer, offering a personalized and minimally invasive alternative to surgery or whole-gland radiation.